Skin Neoplasms
Welcome,         Profile    Billing    Logout  
 42 Companies   55 Products   55 Products   62 Mechanisms of Action   3 Trials   315 News 


«1234567»
  • ||||||||||  Enrollment closed, Trial primary completion date, Surgery:  Intracutaneous Versus Transcutaneous Sutures in the Face (IC vs TC Sutures) (clinicaltrials.gov) -  Apr 25, 2015   
    P=N/A,  N=120, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Apr 2016
  • ||||||||||  Trial completion:  Sun Protection of Kidney Transplant Recipients (clinicaltrials.gov) -  Apr 23, 2015   
    P=N/A,  N=335, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Apr 2016 Enrolling by invitation --> Completed
  • ||||||||||  Trial completion, Enrollment change:  Safety Study of a Fluorescent Marker to Visualize Cancer Cells (clinicaltrials.gov) -  Apr 21, 2015   
    P1,  N=21, Completed, 
    Recruiting --> Terminated; Because there were no responses Recruiting --> Completed | N=30 --> 21
  • ||||||||||  vatalanib (PTK787) / Novartis, Bayer
    Trial primary completion date, Combination therapy, Metastases:  Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) -  Apr 19, 2015   
    P1,  N=96, Active, not recruiting, 
    Recruiting --> Completed | N=30 --> 21 Trial primary completion date: Dec 2014 --> Dec 2015
  • ||||||||||  Trial primary completion date:  Potential Research Study Participant Registry (clinicaltrials.gov) -  Apr 16, 2015   
    P=N/A,  N=200, Recruiting, 
    Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Jan 2015 --> Jan 2025
  • ||||||||||  sirolimus / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma (clinicaltrials.gov) -  Mar 3, 2015   
    P2,  N=1, Terminated, 
    Trial primary completion date: Jan 2016 --> Jan 2017 N=43 --> 1 | Recruiting --> Terminated | Trial primary completion date: Nov 2014 --> Jun 2014; Poor accrual
  • ||||||||||  Trial completion, Enrollment change:  Helping Children be Safe Outdoors With Sun Protection (clinicaltrials.gov) -  Feb 24, 2015   
    P=N/A,  N=840, Completed, 
    N=43 --> 1 | Recruiting --> Terminated | Trial primary completion date: Nov 2014 --> Jun 2014; Poor accrual Enrolling by invitation --> Completed | N=2000 --> 840
  • ||||||||||  Enrollment status, Trial primary completion date:  Sun Protection of Kidney Transplant Recipients (clinicaltrials.gov) -  Feb 23, 2015   
    P=N/A,  N=360, Enrolling by invitation, 
    Enrolling by invitation --> Completed | N=2000 --> 840 Recruiting --> Enrolling by invitation | Trial primary completion date: Oct 2014 --> Apr 2015
  • ||||||||||  Odomzo (sonidegib) / Sun Pharma, buparlisib (AN2025) / Novartis, Adlai Nortye
    Enrollment open, Trial initiation date, Trial primary completion date, Metastases:  Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma (clinicaltrials.gov) -  Feb 19, 2015   
    P=N/A,  N=40, Recruiting, 
    Initiation date: Dec 2014 --> May 2015 Not yet recruiting --> Recruiting | Initiation date: Nov 2014 --> Feb 2015 | Trial primary completion date: Nov 2016 --> Feb 2017
  • ||||||||||  carboplatin / Generic mfg.
    Enrollment closed, Trial primary completion date:  Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck (clinicaltrials.gov) -  Feb 19, 2015   
    P3,  N=321, Active, not recruiting, 
    Not yet recruiting --> Recruiting | Initiation date: Nov 2014 --> Feb 2015 | Trial primary completion date: Nov 2016 --> Feb 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Dec 2016
  • ||||||||||  Trial primary completion date:  Post-Approval Study of MelaFind (clinicaltrials.gov) -  Feb 3, 2015   
    P=N/A,  N=720, Recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Dec 2014 --> Mar 2016
  • ||||||||||  Trial initiation date, Trial primary completion date:  Reducing Skin Cancer Risk in Childhood Cancer Survivors (clinicaltrials.gov) -  Jan 28, 2015   
    P=N/A,  N=801, Enrolling by invitation, 
    Trial primary completion date: Jan 2015 --> Jun 2016 Initiation date: Sep 2014 --> Mar 2015 | Trial primary completion date: Sep 2016 --> Apr 2018
  • ||||||||||  Trial primary completion date:  Safety Study of a Fluorescent Marker to Visualize Cancer Cells (clinicaltrials.gov) -  Jan 9, 2015   
    P1,  N=30, Recruiting, 
    Initiation date: Sep 2014 --> Mar 2015 | Trial primary completion date: Sep 2016 --> Apr 2018 Trial primary completion date: Aug 2014 --> Feb 2015
  • ||||||||||  Veregen (sinecatechins) / Sinphar Pharma, Medigene
    Enrollment status:  Topical Green Tea Ointment in Treatment of Superficial Skin Cancer (clinicaltrials.gov) -  Jan 9, 2015   
    P2/3,  N=42, Recruiting, 
    Trial primary completion date: Aug 2014 --> Feb 2015 Enrolling by invitation --> Recruiting
  • ||||||||||  Hiltonol (poly-ICLC) / Oncovir
    Trial completion, Trial initiation date, Trial primary completion date, IO biomarker:  Safety Study of Adjuvant Vaccine to Treat Melanoma Patients (clinicaltrials.gov) -  Jan 8, 2015   
    P2,  N=35, Completed, 
    Recruiting --> Active, not recruiting Not yet recruiting --> Completed | Initiation date: Nov 2014 --> Sep 2010 | Trial primary completion date: Oct 2015 --> Mar 2013
  • ||||||||||  Veregen (sinecatechins) / Sinphar Pharma, Medigene
    Enrollment open:  Topical Green Tea Ointment in Treatment of Superficial Skin Cancer (clinicaltrials.gov) -  Dec 7, 2014   
    P2/3,  N=42, Enrolling by invitation, 
    Not yet recruiting --> Recruiting Not yet recruiting --> Enrolling by invitation
  • ||||||||||  Trial primary completion date:  Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer (clinicaltrials.gov) -  Nov 23, 2014   
    P=N/A,  N=110, Suspended, 
    Not yet recruiting --> Recruiting | N=380 --> 120 Trial primary completion date: Apr 2014 --> Jun 2015
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date, Cytology:  Nanocytology Test to Evaluate Skin Cancer in High Risk Patients (clinicaltrials.gov) -  Nov 19, 2014   
    P=N/A,  N=7, Completed, 
    N=67 --> 0 | Terminated --> Withdrawn Recruiting --> Completed | N=30 --> 7 | Trial primary completion date: Jun 2014 --> Nov 2014
  • ||||||||||  Hiltonol (poly-ICLC) / Oncovir
    Trial initiation date, Trial primary completion date, IO biomarker:  Safety Study of Adjuvant Vaccine to Treat Melanoma Patients (clinicaltrials.gov) -  Oct 28, 2014   
    P2,  N=33, Not yet recruiting, 
    Recruiting --> Completed | N=30 --> 7 | Trial primary completion date: Jun 2014 --> Nov 2014 Initiation date: Sep 2010 --> Nov 2014 | Trial primary completion date: Oct 2013 --> Oct 2015
  • ||||||||||  Hiltonol (poly-ICLC) / Oncovir
    Enrollment change, Trial termination:  Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) (clinicaltrials.gov) -  Oct 28, 2014   
    P2,  N=8, Terminated, 
    Initiation date: Sep 2010 --> Nov 2014 | Trial primary completion date: Oct 2013 --> Oct 2015 N=20 --> 8 | Active, not recruiting --> Terminated; PI discretion, low enrollment
  • ||||||||||  Biomarker, Enrollment open, IO biomarker, Metastases:  Biomarker Correlates of Hypoxia in Metastatic Melanoma (clinicaltrials.gov) -  Oct 22, 2014   
    P2,  N=36, Recruiting, 
    N=20 --> 8 | Active, not recruiting --> Terminated; PI discretion, low enrollment Not yet recruiting --> Recruiting
  • ||||||||||  Erivedge (vismodegib) / Roche
    Trial completion, Enrollment change, Trial primary completion date, Surgery:  Vismodegib for Treatment of Basal Cell Carcinoma (clinicaltrials.gov) -  Sep 28, 2014   
    P2,  N=3, Completed, 
    Active, not recruiting --> Completed Not yet recruiting --> Completed | N=81 --> 3 | Trial primary completion date: Mar 2013 --> Jun 2013
  • ||||||||||  Veregen (sinecatechins) / Sinphar Pharma, Medigene
    Trial initiation date, Trial primary completion date:  Topical Green Tea Ointment in Treatment of Superficial Skin Cancer (clinicaltrials.gov) -  Sep 16, 2014   
    P2/3,  N=42, Not yet recruiting, 
    Not yet recruiting --> Completed | N=81 --> 3 | Trial primary completion date: Mar 2013 --> Jun 2013 Initiation date: Mar 2014 --> Sep 2014 | Trial primary completion date: Dec 2014 --> Mar 2015
  • ||||||||||  Enrollment open:  Sun Protection of Kidney Transplant Recipients (clinicaltrials.gov) -  Aug 1, 2014   
    P=N/A,  N=367, Recruiting, 
    Trial primary completion date: Dec 2015 --> Dec 2014 Not yet recruiting --> Recruiting